We are live on ! Find out more
VIVO

Meridian Bioscience Inc

Delisted

VIVO was delisted on the 30th of January, 2023.

177 hedge funds and large institutions have $615M invested in Meridian Bioscience Inc in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

657% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $281K

41% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 49

14% more capital invested

Capital invested by funds: $541M → $615M (+$74.1M)

5% less funds holding

Funds holding: 186177 (-9)

27% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 22

Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
4.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
69
Reduced
49
Closed
22
Calls
$2.13M
Puts
$281K
Net Calls
+$1.85M
Net Calls Change
+$1.38M
Name Holding Trade Value Shares
Change
Change in
Stake
American Century Companies
51
American Century Companies
Missouri
$1.78M -$281K -18,818 -14%
TCIM
52
TIAA CREF Investment Management
New York
$1.77M +$191K +12,807 +13%
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$1.66M +$37.6K +2,520 +2%
HW
54
Hancock Whitney
Mississippi
$1.5M +$94.9K +6,365 +7%
Legal & General Group
55
Legal & General Group
United Kingdom
$1.49M +$68.8K +4,613 +5%
PCM
56
Piermont Capital Management
Missouri
$1.46M +$1.36M +91,500 New
VRS
57
Virginia Retirement Systems
Virginia
$1.43M +$1.49K +100 +0.1%
AIM
58
Alambic Investment Management
California
$1.42M -$1.07M -71,893 -45%
SFI
59
Susquehanna Fundamental Investments
Pennsylvania
$1.41M +$360K +24,159 +37%
GIM
60
Greylin Investment Management
Virginia
$1.39M -$22.7K -1,525 -2%
California Public Employees Retirement System
61
California Public Employees Retirement System
California
$1.37M +$33K +2,210 +3%
AIMCA
62
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.35M +$795K +53,300 +169%
Los Angeles Capital Management
63
Los Angeles Capital Management
California
$1.33M
Russell Investments Group
64
Russell Investments Group
United Kingdom
$1.28M +$341K +22,867 +40%
AllianceBernstein
65
AllianceBernstein
Tennessee
$1.22M -$37.3K -2,500 -3%
TA
66
Teachers Advisors
New York
$1.21M +$7.89K +529 +0.7%
Swiss National Bank
67
Swiss National Bank
Switzerland
$1.17M
Arrowstreet Capital
68
Arrowstreet Capital
Massachusetts
$1.11M +$110K +7,380 +12%
Connor, Clark & Lunn Investment Management (CC&L)
69
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.09M +$349K +23,425 +52%
AQR Capital Management
70
AQR Capital Management
Connecticut
$1.04M +$6.38K +428 +0.7%
Bessemer Group
71
Bessemer Group
New Jersey
$1.01M
California State Teachers Retirement System (CalSTRS)
72
California State Teachers Retirement System (CalSTRS)
California
$1.01M +$5.34K +358 +0.6%
ASRS
73
Arizona State Retirement System
Arizona
$980K -$76.3K -5,117 -8%
Citigroup
74
Citigroup
New York
$953K -$288K -19,285 -24%
Canada Life
75
Canada Life
Manitoba, Canada
$919K -$239 -16 -0%

VIVO Hedge Fund Activity: Q2 2018 in Review

177 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2018, worth a combined $615M — up 14% from $541M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VIVO and 16 opened new positions — a net loss of 6 holders — while 49 trimmed existing stakes and 69 added.

The largest buyer was BlackRock, adding an estimated $7.74M. The largest seller was Millennium Management, cutting an estimated $5.9M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2018, down from 186 in Q1 2018.
  • Funds reported $615M of Meridian Bioscience Inc stock for Q2 2018, up 14% quarter-over-quarter.
  • 16 funds opened new Meridian Bioscience Inc positions in Q2 2018 and 22 closed out, a net change of -6 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2018 was BlackRock, an estimated $7.74M added.
  • The largest Meridian Bioscience Inc seller in Q2 2018 was Millennium Management, an estimated $5.9M sold.

Based on aggregated 13F filings for Q2 2018.